Tiziana Life Sciences Plc (TLSA)
NASDAQ:TLSA

Tiziana Life Sciences (TLSA) Financial Statements

462 Followers

Tiziana Life Sciences Financial Overview

Tiziana Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.154; its P/E ratio is -4.74; Tiziana Life Sciences is scheduled to report earnings on September 27, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 19
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 18.12M$ 26.54M$ 42.19M$ 38.60M$ 153.00K
Total Assets$ 26.48M$ 35.13M$ 48.83M$ 41.93M$ 1.81M
Total Debt$ 365.00K$ 0.00$ 0.00$ 831.00K$ 623.00K
Net Debt$ -17.76M$ -26.54M$ -42.19M$ -37.77M$ 470.00K
Total Liabilities$ 122.58M$ 5.28M$ 7.55M$ 6.64M$ 5.99M
Stockholders Equity$ -96.80M$ 29.85M$ 41.28M$ 35.29M$ -4.18M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Tiziana Life Sciences Earnings and Revenue History


Tiziana Life Sciences Debt to Assets


Tiziana Life Sciences Cash Flow


Tiziana Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis